262 related articles for article (PubMed ID: 21159652)
1. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
2. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
4. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
5. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
6. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
7. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
Incoronato M; Garofalo M; Urso L; Romano G; Quintavalle C; Zanca C; Iaboni M; Nuovo G; Croce CM; Condorelli G
Cancer Res; 2010 May; 70(9):3638-46. PubMed ID: 20388802
[TBL] [Abstract][Full Text] [Related]
8. No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.
Pallier K; Houllier AM; Le Corre D; Cazes A; Laurent-Puig P; Blons H
Mol Carcinog; 2009 Jul; 48(7):581-5. PubMed ID: 19353596
[TBL] [Abstract][Full Text] [Related]
9. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA signature predicts survival and relapse in lung cancer.
Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC
Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137/PXN axis in non-small cell lung cancer.
Jiang H; Zhang H; Hu X; Li W
Int J Biol Macromol; 2018 May; 111():623-631. PubMed ID: 29337100
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
Crawford M; Brawner E; Batte K; Yu L; Hunter MG; Otterson GA; Nuovo G; Marsh CB; Nana-Sinkam SP
Biochem Biophys Res Commun; 2008 Sep; 373(4):607-12. PubMed ID: 18602365
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
15. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
